{"title": "World Journal of Gastroenterology", "author": null, "url": null, "hostname": null, "description": null, "sitename": null, "date": "2023-01-01", "cleaned_text": "Thein, Chang Yell Shin, Uy Dong Sohn. Inhibitory effects of Humulus japonicus extract against hepatic injury in a diabetic rat model. Food Science and Biotechnology 2021; 30(7): 979 doi: |2|| | Kyong Kim, Minho Lee, Eun-Young Park, Dong Jae Baek, Chul Kim, Hee-Sook Jun, Yoon Sin Oh. Allomyrina dichotoma Larva Extract Ameliorates the Hepatic He, Jianping Jiang, Zhiyun Chen. Prediction of VEGF-C as a Key Target of Pure Total Flavonoids From Citrus Against NAFLD in Mice via Network Pharmacology. Frontiers in Pharmacology 2019; 10 doi: |4|| miR-122 promotes hepatic lipogenesis via inhibiting the LKB1/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease. Molecular Medicine 2019; 25(1) |5|| on | Maret G. Traber, Brian Head. Vitamin E: How much is enough, too much and why!. Free Radical Biology and Medicine Protective Effects of Thymoquinone on Hepatic Injury\u2014A Systematic Review of In Vivo Studies. Journal Molecular Sciences 2018; |9|| Sheng, Yang Chen, Ying-qian Cao, Chen Chen. Molecular mechanisms of hepatic insulin resistance in nonalcoholic fatty liver disease and 159: 104984 doi: |10|| | Seungho Kim, Ju-Hee Kang, Dongyun Shin, Yeong-Su Jang, Yeo physiological concentration phenylalanine-proline can ameliorate cholesterol in induced non-alcoholic fatty liver disease by regulation of FoxO1 mediated pathway. Pharmacological Reports 2017; 69(4): 666 doi: |13|| | Jie Zhou, Chi-Tang Ho, Piaopiao Long, Qilu Meng, Liang Zhang, Xiaochun Wan. Preventive Efficiency of Green Tea and Its Components on Nonalcoholic Fatty Liver Disease. Journal of Agricultural and Food 5306 Jun Luo, Lingyi Kong, Wenjun Xu. Hyperbenzones A and B, rearranged phase 2 doubleblind study Xin Xu, Jiangbo Jin, Zhan, Tianyu Han, Wang. acid-induced HepG2 inhibiting lipogenesis and oxidative stress. Chen, Jun Liu. 3-Acetyl-oleanolic acid ameliorates non-alcoholic fatty liver disease in high fat Yang. AP39 ameliorates high fat diet-induced liver injury in young rats via alleviation of oxidative stress and mitochondrial impairment. Experimental Formulation in Non-Alcoholic Fatty Liver Disease: A Sayali Exploring the Gamut of Receptor Tyrosine Kinases for Their Promise in the Management of Disease. Biomedicines Igor V. Brandi, Deborah F Lelis, Sergio H. S. Santos. The role of the angiotensin II type I receptor blocker telmisartan in the treatment of non-alcoholic fatty liver disease: a brief review. Hypertension Research 2018; Health-related quality of life burden of nonalcoholic steatohepatitis: a robust pragmatic literature review. Journal of modified choline-deficient l Hessah Kamal Amin. on by regulating stearoylCoA desaturase1, lipase activity, A on high-fat diet-induced non-alcoholic fatty liver disease by acting as an LXR/FXR dual receptor activator. Frontiers in Biondo, Alexandre A. S. Teixeira, Karen C. de O. S. Ferreira, Jose C. R. Neto. Pharmacological Strategies for Insulin Sensitivity in Obesity and Cancer: Thiazolidinediones and Metformin. Current Pharmaceutical Design 2020; 26(9): 932 |27|| | Jing Gao, by modulating hepatic lipid metabolism in C57BL/6J mice. Journal of Functional Foods 2019; 54: 254 doi: |28|| | Mingzhe Zhu, Meng Li, Wenjun Zhou, Yang Yang, Fenghua Li, Li Zhang, Guang Ji. Qianggan extract improved nonalcoholic steatohepatitis by modulating lncRNA/circRNA immune Non-Alcoholic Liver Diseases: Promising Molecular Drug Targets and their Clinical Development. Current Drug Discovery Technologies 2021; 18(3): 333 doi: |31|| | Rong Sainan Li, Yuqing Zhou, Shunfeng Zhou, Rui Kong, Linqiang Li, Jingjing Li, Jiao Feng, Liwei Wu, Tong Liu, Yujing Xia, Jie Lu, Chuanyong Guo, Zhou. Metformin Capsule Alone in Patients with Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus. Gastroenterology Research and Practice 2017; 2017: 1 doi: |32|| | Mi Ra Lee, Hye Jin Yang, Kwang Il Park, Jin Yeul Ma. Xiaohong Xi Liang, Youyou Jingfeng Wang, Lanwei Zhang. Lactobacillus casei YRL577 combined with plant extracts reduce markers of non-alcoholic fatty liver disease in mice. British Journal of Nutrition 2021; 125(10): 1081 doi: |34|| | Yanxin Zhao, Yaru Zhou. Effect of 5:2 Fasting Diet on Liver Fat Content in Patients with Type 2 Diabetic with Nonalcoholic Fatty Liver Disease. Metabolic Syndrome and Related Suk. The seamless integration of dietary plant-derived natural flavonoids and gut microbiota may ameliorate non-alcoholic fatty liver disease: a network pharmacology 51(1): 217 |36|| Kairui Tang, Yupei Zhang, Qinhe Yang. Lipidomic Analysis of the Protective Effects of Shenling Baizhu San on Non-Alcoholic Fatty Liver Disease 2019; 24(21): 3943 doi: |37|| | Eunsook S. Jin, A. Dean Sherry, Craig R. Malloy. An Oral Load of [13C3]Glycerol and Blood NMR Analysis Detect Fatty Acid Esterification, Pentose Phosphate Pathway, and Glycerol Metabolism through the Tricarboxylic Acid Cycle in Human Liver. Journal of Biological Chemistry model of Therapeutic Effects of the Diet on Non-Alcoholic Steatohepatitis (NASH) Induced by \"Junk Food\": Michael Goedken, Angela Slitt, Navindra P. Seeram, Hang Ma. Hepatoprotective and anti-inflammatory effects of a standardized pomegranate (Punica granatum) fruit extract in high fat diet-induced obese C57BL/6 mice. International Journal of Food Sciences and Nutrition 2021; 72(4): 499 doi: |41|| | Maureen Whitsett, Lisa B VanWagner. Physical activity as a treatment of non-alcoholic fatty liver disease: A systematic review. World Journal of Yang, Chuan-zheng as a ceRNA in regulating hepatic lipogenesis competitively binding 1 doi: |43|| | Eun\u00fcs S. Ali, Nikolai Petrovsky. Calcium Signaling As a Therapeutic Target for Liver Steatosis. Trends in Endocrinology & Metabolism 2019; Chen. alleviates fatty acidinduced lipid accumulation in mouse primary hepatocytes through the activation ofPPARsignals. Journal of Cellular and Molecular 2019; 23(6): Abdullah. Thioacetamide potentiates high cholesterol and high fat diet induced steato-hepatitic changes in livers of C57BL/6J mice: A novel eight weeks model of fibrosing NASH. Toxicology Letters 2019; 304: Tocotrienol-Rich Fraction Vitamin E in Non-alcoholic Fatty Liver Disease in Obese Children and Adolescents. Frontiers in Pediatrics 2021; 9 doi: |47|| | Qingqing Yu, Yayun Liu, Yufei Wu, Yong Chen. Dihydrocurcumin ameliorates the lipid accumulation, oxidative stress and insulin resistance in oleic acid-induced Bin Cheng, Xiao-Min Yao, Juan Wang, Daniel Dias Rufino Arcanjo. Mechanism of Huo-Xue-Qu-Yu Formula in Treating Nonalcoholic Hepatic Steatosis by Regulating Lipid Metabolism and Oxidative Stress in Rats. Evidence-Based Complementary and Alternative Medicine 2021; 2021: 1 doi: |49|| | Yayun Liu, Lu Liao, Yong Chen, Fengmei Han. Effects of daphnetin on lipid metabolism, insulin resistance and oxidative stress in OAtreated HepG2 cells. Molecular Medicine Reports 2019; doi: |50|| | QIAN XU, JI WANG, FEIFEI CHEN, KAISU LIN, MINGAO ZHU, LEI CHEN, XIUMIN ZHOU, CHONG LI, HONG ZHU. Protective role of magnesium isoglycyrrhizinate in non-alcoholic fatty liver disease and the associated molecular mechanisms. International Journal of Molecular Medicine 2016; 38(1): 275 doi: Paolo Magni, Raul D. Santos, Ginny Jacobs, Suzanne Murray. Clinical practice gaps and challenges in nonalcoholic steatohepatitis care: An international physician needs development of nonalcoholic steatohepatitis in Tsumura Suzuki Obese improves fatty infiltration indices and liver fibrosis scores in patients with non-alcoholic fatty liver disease and metabolic syndrome. Arab Journal of Gastroenterology 22(1): 1 doi: |54|| | Jella-Andrea Abraham, Olga Time for paradigm change in management of hepatocellular carcinoma: is a personalized approach on the horizon?. Personalized Medicine 2016; 13(5): 455 doi: |55|| | Jian ZHOU, Sian XU, Yue ZHU, Xin LI, Ao WANG, Junfang HU, Li LI, Yan LIU. Inhibition of neuropilin-1 improves non-alcoholic fatty liver disease Abdo Yahya. Hypoglycemic, and Hepatoprotective Impacts of Pearl Millet (Pennisetum glaucum L.) Grains and Their Ethanol Extract on Rats Fed a High-Fat Diet. Nutrients 2022; 14(9): Shahat, Mohamed R. Mohamed, Wagdy K. B. Khalil, Ahmed M. Salem, Abdel Razik H. Farrag, Hanaa H. Ahmed. diet-induced nonalcoholic steatohepatitis in rats: analysis of potential mechanisms. Journal Pharmaceutical Investigation 2021; 51(2): 183 Gong, Meixing Yan. Pink Lotus Essential Oil and Alleviates on Free Fatty Acid Induced Steatosis in HepG2 Cells 2022; doi: |60|| | Xin Sun, Yan Zhang, Meilin Xie. The role of peroxisome proliferator-activated receptor in the treatment of non-alcoholic Acta Pharmaceutica 2017; 67(1): C. Verna. Nonalcoholic Fatty Liver Disease. Clinics in Disease doi: |62|| | Yan Lin Zhang Jinwen. Effects of extracts from soothing-liver and invigorating-spleen formulas on the injury induced by oxidative stress in the hepatocytes of rats with non-alcoholic fatty liver disease induced by high-fat diet. Journal of Traditional Chinese Medicine 2018; 38(4): 535 doi: |63|| | Li Cao, Ying Wu, Wenwen Li, Zengmiao Zhang, Yaping Niu, Chenchen Li, Shaobin Gu. officinalis vinegar reduces body weight attenuates hepatic steatosis in mouse model of nonalcoholic fatty against acute liver steatosis in adult zebrafish experimental model. Comparative Biochemistry and Pharmacology 2021; 247: M. Yasmen F. Mahran, Hala A. Attia. The Renin Angiotensin System in Cancer, Lung, Liver and Infectious Diseases. Advances in Biochemistry in Health and Disease 2023; Antioxidant Drug to Reverse Hepatic Steatosis: Experimental Model. Canadian Gastroenterology and Hepatology 2020; 2020: 1 doi: |67|| | N. Ashraf, T. A. Sheikh. Endoplasmic reticulum stress and Oxidative stress in the pathogenesis of Non-alcoholic fatty liver disease. ligand for Kim, Chul-Hee Kim, Sung-Koo Kang, Ji-Oh Mok. Association of grade of non-alcoholic fatty liver disease and glycated albumin to glycated hemoglobin ratio in patients with type 2 diabetes mellitus. Diabetes Research and Clinical Practice 2017; 125: 53 NAFLD and nutraceuticals: a review of completed phase III and IV clinical trials. Frontiers in Medicine 2023; 10 doi: |71|| | Jin Liu, Yinglin Yuan, Xia Gong, Liangke Zhang, Qin Zhou, Shengwang Wu, Xue Zhang, Jun Hu, Ge Kuang, Xinru Yin, Yuan. Baicalin and its nonalcoholic fatty liver disease via suppression of mice. International Immunopharmacology 2020; 80: 106208 |72|| | Tong Lin, Caijun Liang, Lisheng Peng, Weicheng Hu. Network Pharmacology-Based Investigation of the Therapeutic Mechanisms of Action of Danning Tablets in Nonalcoholic Fatty Liver Disease. Evidence-Based Complementary activation and bariatric a comprehensive review. Sao Paulo Medical Journal Lipid Accumulation and Leads to Mild Changes in Inflammationin NASH Mice. Frontiers in Immunology 2021; 12 doi: |76|| | Atilla Engin. Obesity and 960: Hiane. An Overview of Novel Dietary Supplements and Food Ingredients in Patients with Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease. Molecules 2018; Xiaofan Ma, Yuying Pan, Gengsheng Li. Evodiamine decreased the systemic exposure of pravastatin in non-alcoholic steatohepatitis rats due to the Bo Cui. Lycium barbarum Oligosaccharides Alleviate Hepatic Steatosis Modulating Gut rs738409 underlies treatment response in nonalcoholic fatty liver Cotransporter 2 Inhibitors in Patients With Concurrent Type 2 Diabetes Mellitus and Non-Alcoholic Steatohepatitis: A Review of the Evidence. Frontiers in Endocrinology 2021; 12 doi: |82|| | Rong Yang, Huili Yang, Dansheng Jiang, Linyi Xu, Lian Feng, Yufeng Xing. Investigation of the potential mechanism of the Shugan Xiaozhi decoction for the treatment of nonalcoholic fatty liver disease based on network pharmacology, molecular docking molecular dynamics simulation. the Mice. Nutrients 2019; 11(12): 3044 | Ma, Congyong Li, Wenwen Deng, Michael AduFrimpong, Jiangnan Yu, Ximing Xu. Extraction and structural analysis of Angelica sinensis polysaccharide with low molecular weight and its lipidlowering effect on nonalcoholic fatty liver disease. Food Science steatosis in an in vitro in vivo 2018; 3725 Ju-Hee Lee. Berteroin ameliorates lipid accumulation through AMPK-mediated regulation of hepatic lipid metabolism and inhibition Trebicka. Combination of CCl4 with alcoholic and metabolic injuries mimics human liver fibrosis. American Journal of Physiology-Gastrointestinal Liver doi: |90|| | Jiaping Zheng, Sijie Chen, Lin, Sujie Ke, Libin Liu. Insufficient nocturnal sleep was associated with a higher risk of fibrosis in patients with diabetes with metabolic associated fatty liver disease. Therapeutic Advances in Clinics in Liver Disease 2016; 20(2): 351 doi: |92|| | Cheng Ma, Cheng Wang, Yafang Zhang, Honglin Zhou, Yunxia Li. Potential Natural Compounds for the Prevention and Treatment of Nonalcoholic Fatty Liver Disease: A Review on Molecular "}